Skip to main content
. 2024 Oct 7;5(10):837–843. doi: 10.1302/2633-1462.510.BJO-2024-0055.R1

Table III.

Unweighted outcomes in obese patients with and without metabolic syndrome.

Complication or other outcome Obese with MetS, % Obese without MetS, % p-value
Length of stay, days 3.3 3.2 < 0.0001*
Discharge home 61.03 68.35 < 0.0001
Central nervous system 0.07 0.08 0.8346
Cardiac 0.72 0.55 < 0.0001
Deep vein thrombosis 0.34 0.34 0.9913
Gastrointestinal 0.26 0.22 0.0163
Genitourinary 0.57 0.41 < 0.0001
Haematoma/seroma 0.55 0.54 0.6762
Postoperative infection 0.15 0.15 0.9265
Pulmonary embolism 0.4 0.45 0.3785
Postoperative anaemia 24.67 21.38 < 0.0001
Peripheral vascular disease 0.10 0.11 0.6005
Respiratory 0.13 0.14 0.6673
Wound dehiscence 0.11 0.10% 0.3623
*

Independent-samples t-test.

Chi-squared test.

MetS, metabolic syndrome.